Back to Search
Start Over
Cost-effectiveness of alternative strategies for interferon-γ release assays and tuberculin skin test in tuberculous uveitis.
- Source :
-
The British journal of ophthalmology [Br J Ophthalmol] 2015 Jul; Vol. 99 (7), pp. 984-9. Date of Electronic Publication: 2015 Jan 08. - Publication Year :
- 2015
-
Abstract
- Background: Although tuberculous uveitis remains a major cause of ocular morbidity in the developing world, there is no consensus on which diagnostic test or testing strategy is the most cost effective. In this study we carried out a cost-effectiveness analysis to determine the most cost-effective diagnostic test strategy.<br />Methods: In this prospective study, we recruited 102 patients from Singapore National Eye Centre with signs suggestive of tuberculous uveitis. Using prospective data from this cohort and from published meta-analyses, we modelled the incremental cost effectiveness of the following strategies: tuberculin skin test (TST) only; interferon-γ release assay (IGRA) only; IGRA following a positive TST result; and dual-test strategy, conducting TST and IGRA at presentation. Incremental cost-effectiveness ratios (ICERs) were calculated for each strategy and analysed using a willingness-to-pay threshold of $50,000 per quality-adjusted life year (QALY) gained.<br />Results: In our population, the least cost effective was the IGRA-only strategy. The dual-test strategy was the most cost effective, with an improvement of 0.017 QALY at an incremental cost of $190 relative to the TST-only strategy (ICER $11,500); while the TST-only strategy was more cost effective than the third strategy, using IGRA following a positive TST result (ICER $3610). This remained consistent while varying the costs of IGRA and TST, the incidence of tuberculosis and tuberculous uveitis, as well as the diagnostic accuracy of IGRA and TST found in previous studies in various populations.<br />Conclusions: The dual-test strategy (performing TST and IGRA at presentation) was the most cost effective strategy for the diagnosis of tuberculous uveitis in our population.<br /> (Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.)
- Subjects :
- Aged
Antitubercular Agents therapeutic use
Female
Health Care Costs
Humans
Male
Middle Aged
Models, Economic
Prospective Studies
Quality-Adjusted Life Years
Singapore
Tuberculosis, Ocular drug therapy
Tuberculosis, Ocular economics
Uveitis drug therapy
Uveitis economics
Cost-Benefit Analysis
Interferon-gamma Release Tests economics
Tuberculin Test economics
Tuberculosis, Ocular diagnosis
Uveitis diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 1468-2079
- Volume :
- 99
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- The British journal of ophthalmology
- Publication Type :
- Academic Journal
- Accession number :
- 25573149
- Full Text :
- https://doi.org/10.1136/bjophthalmol-2014-306285